Strain Name: |
B6 x B6CBCa Aw-J/A-Grid2Lc T(2;6)7Ca MitfMi-wh/J |
|---|---|
Stock Number: |
000593 |
Availability: | Repository-Cryopreserved |
General Terms and Conditions |
| Former Name |
B6 x B6CBACa-Aw-J/A-Grid2Lc T(2;6)7Ca MitfMi-wh (Changed: 15-DEC-04
) |
|
T7Ca (Changed: 15-DEC-04
) | |
| Genes & Alleles | Aw-J; Grid2; Grid2Lc; Mitf; MitfMi-wh; a; T(2;6)7Ca; ; |
Product Information
Strain Details
Type Chromosome Aberration Additional information on Mice with Chromosomal Aberrations. Type JAX® GEMM® Strain - Mutant Strain Additional information on JAX® GEMM® Strains. Type Translocation Additional information on Mice with Chromosomal Aberrations. Species laboratory mouse Generation N2 Strain Description
Mice homozygous for the MitfMi spontaneous mutation are characterized by decreased macrophage chemotactic responses, impaired proliferative responses to B cell and T cell mitogens, diminished responses in vitro to T-dependent and T-independent antigens and reduced NK cell activity.
Gene & Allele Details
| Allele Symbol | Aw-J | ||
|---|---|---|---|
| Allele Name | white bellied agouti Jackson | ||
| Common Name(s) | AWJ; | ||
| Strain of Origin | C57BL/6J | ||
| Gene Symbol and Name | a, nonagouti | ||
| Chromosome | 2 | ||
| Gene Common Name(s) | AGSW; AGTI; AGTIL; ASP; As; MGC126092; MGC126093; SHEP9; agouti; agouti signal protein; agouti suppressor; | ||
| Allele Symbol | Grid2Lc | ||
| Allele Name | lurcher | ||
| Common Name(s) | Grid2-Lc; lc; | ||
| Strain of Origin | STOCK Mitf | ||
| Gene Symbol and Name | Grid2, glutamate receptor, ionotropic, delta 2 | ||
| Chromosome | 6 | ||
| Gene Common Name(s) | B230104L07Rik; GluRdelta2; Lc; LcJ; MGC117022; MGC117023; MGC117024; RIKEN cDNA B230104L07 gene; cpr; creeper; ho; hotfoot; lurcher; lurcher Jackson; neuroscience mutagenesis facility, 408; nmf408; tapdancer; tpr; | ||
| General Note | Lurcher arose as a spontaneous mutation in a male homozygous for the microphthalmia allele white (Mitfmi-wh). Heterozygotes show a characteristic swaying of the hindquarters and a jerky up and down movement. They are identifiable with certainty by their behavior at 12 to 14 days of age. They are smaller than normal at maturity, but are fertile and have a normal life span (J:289).Homozygotes die shortly after birth. They have no visible abnormalities (J:289), but show severe postnatal loss ofPurkinje cells and granule cells. Virtually no Purkinje cells are found in adults and granule cells are reduced to about 10% of normal. The number of neurons in the inferior olivary nucleus falls to about 25% of normal. Other cell populations are normal (J:6232, J:5786).Wetts and Herrup (J:6841, J:6931), using chimeras of Grid2Lc/+ with wild-type mice in which the lurcher and wild type cells are distinguishable by cytoplasmic or nuclear markers, show that the action of lurcher is intrinsic to Purkinje cells and that the loss of granule cells and olive cells is probably secondary. The same authors conclude, from the numbers of wild type Purkinje cells found in different lurcher--wild type chimeras, that the number of Purkinje cell progenitorsis very small, perhaps 8 to 11 in each brain half, and that each progenitor gives rise to about 10,000 Purkinje cells (J:6866, J:12731). The loss of Purkinje cells in lurcher mutants is intrinsic to the cells, as are the morphological abnormalities of these cells prior to their death (J:26094). The Grid2Lc mutation induces apoptotic programmed death of the cerebellar cortical Purkinje cells (J:24329). Purkinje cells from lurcher animals can, however, survive in vitro (J:26917), and deep cerebellar Purkinje cells survive in vivo (J:25957).Grafting of cerebellar tissues from normal mice into adult Grid2Lc/+ mice, either as solid tissues (J:16367) or as a cell suspension (J:14032), causes a partial, but only a partial, reconstructionof cerebellar neural circuitry. Grafted Purkinje cells invade the dorsal cochlear nuclei of lurcher mice, emphasizing the resemblance of this nucleus to cerebellar tissue in some respects (J:15257).Cerebellar Purkinje cells are the target of climbing fibers originating from granule cells and from inferior olivary neurons. The loss of the cerebellar targets results in a decrease in the afferent neuron populations (J:12661). Initial multiple innervation of Purkinje cells, each receiving several climbing fibers, is transient and is succeeded by a one-to-one relationship in normal cerebellum. Due to an intrinsic incompetence of Grid2Lc/+ Purkinje cells, they retain multiple innervation (J:3428).Lurcher mice have motor abnormalities, but not inall motor function tests (J:990), and motor learning is not slowed (J:17180). Although these mice also show deficits in spatial orientation, the two abnormalities are not correlated (J:22285). There is a massive loss of neurons in the cerebellar cortex, but deep cerebellar nuclei are intact, and are sufficient for motor learning of simple tasks (J:25957).Lurcher mice, reproducibly deficient in defined cell populations, have been used to study cerebellar function and the distribution of various brain components on cerebellar cells. Lurcher has been suggested as a model for a human dominant hereditary ataxia, olivopontocerebellar atrophy (OPCA). Inositol triphosphate metabolism is slowed in Grid2Lc/+ mice and in OPCA patients. This metabolic alteration may be associated with the beginnings of degeneration of the Purkinje cells (J:1412). Insulin-like growth factor 1 binding and receptor phosphorylation is also reduced in both lurcher mice and OPCA patients (J:18719).The lurcher mutation maps to Chr 6 near Mitfmi-wh (J:289). Intersubspecific backcross mapping suggests a somewhat more proximal position (J:11037). A high resolution genetic map and a YAC contig of the lurcher locus contributed significantly to the identification of lurcher as a mutation in Grid2 (J:30546). | ||
| Molecular Note | The lurcher (Grid2Lc) and lurcher-J (Grid2Lc-J) mutations are nucleotide substitutions that cause a change in an amino acid in the third transmembrane domain of Grid2. [MGI Ref ID J:42431] | ||
| Allele Symbol | MitfMi-wh | ||
| Allele Name | white | ||
| Common Name(s) | Miwh; | ||
| Strain of Origin | (C57BL x DBA)F1 | ||
| Gene Symbol and Name | Mitf, microphthalmia-associated transcription factor | ||
| Chromosome | 6 | ||
| Gene Common Name(s) | MI; WS2A; bHLHe32; black eyed white; bw; mi; microphthalmia; vit; vitiligo; wh; | ||
| General Note | Combination heterozygotes of MitfMi-wh/MitfMi, MitfMi-wh/MitfMi-b, and MitfMi-wh/MitfMi-ws show some interallelic complementation in that the heterozygote of the two alleles is more nearlynormal than either homozygote (J:12967, J:19656). MitfMi-b/MitfMi-wh agouti mice are light cream with white spots and ruby eyes (J:15061). | ||
| Molecular Note | T to A transversion at bp 764, which leads to an isoleucine to asparagine substitution at the corresponding amino acid (212) in the encoded protein. This mutation is in the basic region of the protein. [MGI Ref ID J:19656] [MGI Ref ID J:21366] | ||
| Gene Symbol and Name | T(2;6)7Ca, reciprocal translocation, Chr 2 and 6, Carter 7 | ||
| Chromosome | 6 | ||
| Gene Common Name(s) | T7Ca; | ||
Genotyping Protocols
Aw-J
Related Strains
Reciprocal Translocations
View Reciprocal Translocations (47 strains)
001046 B6CBACa Aw-J/A-Grid2Lc/J
000158 B6.Cg-MitfMi-wh/MitfMi/J 000184 B6.Cg-MitfMi-wh/Mitfmi-rw/J 000157 B6.Cg-MitfMi-wh/Mitfmi-sp/J 000057 B6.Cg-MitfMi-wh/J 000350 B6By.Cg-KitW-v MitfMi-wh T/J 001253 STOCK MitfMi-wh +/+ Wnt7apx/J 000302 STOCK a/a MitfMi-wh +/+ Itpr1opt/J
Research Applications
This mouse can be used to support research in many areas including:
Grid2Lc relatedResearch Tools
Genetics Research
MitfMi-wh relatedDevelopmental Biology Research
Embryonic Lethality (Homozygous)
Neurobiology Research
Ataxia (Movement) Defects
Cerebellar Defects (Purkinje cell defect)
Receptor Defects (glutamate receptor: ionotropic)
Dermatology Research
Color and White Spotting Defects
Endocrine Deficiency Research
Bone/Bone Marrow Defects
Immunology and Inflammation Research
Immunodeficiency Associated with Other Defects
Mouse/Human Gene Homologs
Waardenburg syndrome, type IIA
Neurobiology Research
Vestibular and Hearing Defects
Sensorineural Research
Eye Defects
Vestibular and Hearing Defects
References
Additional ReferencesPrice and Supply Information
| Strain Name: | B6 x B6CBCa Aw-J/A-Grid2Lc T(2;6)7Ca MitfMi-wh/J |
| Stock Number: | 000593 |
Price Details
IMPORTANT NOTE: Prices are based on shipping destination. To view prices, select your shipping destination.
*NO Shipping Destination selected!
Supply Details
| Standard Supply | Repository-Cryopreserved. Must Be Recovered. Please refer to pricing and supply notes for further information. |
|---|---|
| Supply Notes |
Cryorecovery - Standard. The recovery process begins when a signed agreement form is returned to the Customer Service Department after order placement. Although results vary by strain, at least two males and two females (two pairs) will be provided, typically within 15 weeks of our receipt of the signed agreement form. If the first recovery attempt is unsuccessful or only one pair is recovered, a second recovery will be done, extending the delivery time to approximately 25 weeks. At least one member of each pair will be of known genotype and will carry the mutation if it is a mutant strain. Please note that pairs may not reflect the mating scheme utilized by The Jackson Laboratory prior to cryopreservation of the strain. Mating schemes are sometimes modified for successful cryopreservation. Price represents a repository maintenance fee, which includes the cost of recovery of the strain from the cryopreservation resource and the periodic replacement of the frozen embryos used for recovery. Cryorecovery to establish a Dedicated Supply for greater quantities of mice. |
| Licensing | See General Terms and Conditions below |
General Terms and Conditions
View JAX® Mice & Services Conditions of Use.
The Jackson Laboratory's Genotype Promise
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project.Ordering and Purchasing Information
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 800.422.6423 or 207.288.5845
Fax: 207.288.6150
Technical Support Email Form